期刊文献+

O-羧甲基N-半乳糖化壳聚糖衍生物的设计、合成和表征 被引量:8

Design,Synthesis and Characterization of O-carboxymethyl Galactosylated Chitosan Derivatives
下载PDF
导出
摘要 目的 :合成和表征O 羧甲基 N 半乳糖化壳聚糖衍生物作为潜在的肝靶向基因载体。方法 :以天然聚合物壳聚糖为原料 ,首先制备得O 羧甲基壳聚糖 ,然后在其 2 NH2 上和乳糖酸反应 ,制得O 羧甲基 N 乳糖酰化壳聚糖 ;或与乳糖反应 ,用KBH4还原 ,制得O 羧甲基 N 乳糖胺化壳聚糖。结果与结论 :分别用FT IR、1HNMR、13 CNMR和元素分析对其进行了表征。用粉末X 衍射、DSC、TG对其物理性质进行了分析。制得的O 羧甲基 N 乳糖酰化壳聚糖O 羧甲基 N 乳糖胺化壳聚糖有望作为潜在的肝靶向基因载体。 AIM:To synthesize and to characterize O -carboxymethyl- N -galactosylated chitosan derivatives for potential gene delivery carriers for hepatocyte-targeting.METHOD: Firstly,a water-soluble O -carboxymehyl chitosan(CMCS) was prepared.To give galactosylated O -carboxymethyl Chitosan(Gal-CMCS),lactobionic acid was added and galactose group was introduced into the amino groups of CMCS Lactosaminated O -carboxymethyl chitosan(Lac-CMCS) was prepared by reaction of CMCS and α-lactose,followed by reaction with KBH 4 RESULT and CONCLUSION: FTIR, 1 H NMR , 13 C NMR and elemental analysis characterized the chemical structures of O -carboxymethyl galactosylated chitosan derivatives Some physical behaviors were analyzed by X -ray diffraction(WXRD) and differential scanning calorimetry (DSC) The O -carboxymethyl- Ν -galactosylated chitosan derivatives may be used as potential gene delivery carriers for hepatocyte-targeting
出处 《中国天然药物》 SCIE CAS CSCD 2004年第6期354-358,共5页
基金 国家 973项目资助 (No G19990 64 70 5 )~~
关键词 O-羧甲基N-半乳糖化壳聚糖 衍生物 设计 合成 表征 肝靶向 基因载体 Chitosan Galactose group Synthesis Characterization Hepatocyte-targeting Gene carrier
  • 相关文献

参考文献25

  • 1[1]Ferrare G,Rossini S,Giavazzi R.An in vivo model of somatic-cell gene-therapy for human severe combined between GCP/DNA complex and DOTAP/DNA did immunodeficiency[J].Science,1991,251:1363-1366.
  • 2[2]Leong KW,Mao HQ,Truong-Le VL,et al.J DNA-polycation nanospheres as non-viral gene delivery vehicles[J].Controlled Release,1998,53:183-193.
  • 3[3]De Smedt SC,Demeester J,Hennink WE.Cationic polymer based gene delivery systems[J].Pharm Res,2000,17(2):113-126.
  • 4[4]Garnett MC.Gene-delivery systems using cationic polymers[J].Crit Rev Ther Drug Carrier Syst,1999,16(2):147-207.
  • 5[5]Minagawa K,Matsuzawa Y,Yoshikawa K,et al.Direct observation of the biphasic conformational change of DNA induced by cationic polymers[J].FEBS Lett,1991,295(1-3):67-69.
  • 6[6]Domard A,Cartier N.Glucosamine oligomers:4.Solid state-crystallization and sustained dissolution[J].Int J Biol Macromol,1992,14(2):100-106.
  • 7[7]Roberts GAF Structure of chitin and chitosan,Chitin Chemistry,Roberts GAF Mac Millan Press,Houndmills,1992,1-53.
  • 8[8]Janes KA,Calvo P,Alonso MJ.Polysaccharide colloidal particles as delivery systems for macromolecules[J].Adv Drug Deliv Rev,2001,23:83-97.
  • 9[9]Stolnik S,Illum L,Davis SS.Long circulating microparticulate drug carriers[J].Adv Drug Deliv Rev,1995,16:195-214.
  • 10[10]Ishida O,Maruyama K,Sasaki K,et al.Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice[J].Int J Pharm,1999,190:49-56.

同被引文献156

引证文献8

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部